Key facts
- This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Tax liability
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,590 shares of restricted stock, the grant of which was previously reported on February 18, 2025.
Footnote F2
Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,355 shares of restricted stock, the grant of which was previously reported on February 16, 2024.
Footnote F3
The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.